Tallman MS - Search Results

1

Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.

Sanz MA, Fenaux P, Tallman MS, Estey EH, Löwenberg B, Naoe T, Lengfelder E, Döhner H, Burnett AK, Chen SJ, Mathews V, Iland H, Rego E, Kantarjian H, Adès L, Avvisati G, Montesinos P, Platzbecker U, Ravandi F, Russell NH, Lo-Coco F. Sanz MA, et al. Among authors: tallman ms. Blood. 2019 Apr 11;133(15):1630-1643. doi: 10.1182/blood-2019-01-894980. Epub 2019 Feb 25. Blood. 2019. PMID: 30803991 Free PMC article. Review.

2

Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.

Tallman MS, Kwaan HC. Tallman MS, et al. Blood. 1992 Feb 1;79(3):543-53. Blood. 1992. PMID: 1732003 Free article. Review. No abstract available.

3

Detection of differentiation in acute promyelocytic leukemia.

Tallman MS, Kwaan HC, Weitzman SA. Tallman MS, et al. Blood. 1991 Oct 1;78(7):1892-3. Blood. 1991. PMID: 1912572 Free article. No abstract available.

4

Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.

Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P, Bennett JM, Tallman MS, Wiernik PH. Gallagher RE, et al. Among authors: tallman ms. Blood. 1995 Aug 15;86(4):1540-7. Blood. 1995. PMID: 7632962 Free article.

5

All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.

Tallman MS. Tallman MS. Semin Hematol. 1994 Oct;31(4 Suppl 5):38-48. Semin Hematol. 1994. PMID: 7831584 Review.

6

Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid.

Tallman MS, Rowe JM. Tallman MS, et al. Blood Rev. 1994 Jun;8(2):70-8. doi: 10.1016/s0268-960x(05)80010-4. Blood Rev. 1994. PMID: 7950477 Review. No abstract available.

7

RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study.

Li YP, Andersen J, Zelent A, Rao S, Paietta E, Tallman MS, Wiernik PH, Gallagher RE. Li YP, et al. Among authors: tallman ms. Blood. 1997 Jul 1;90(1):306-12. Blood. 1997. PMID: 9207466 Free article.

8

Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.

Gallagher RE, Willman CL, Slack JL, Andersen JW, Li YP, Viswanatha D, Bloomfield CD, Appelbaum FR, Schiffer CA, Tallman MS, Wiernik PH. Gallagher RE, et al. Among authors: tallman ms. Blood. 1997 Aug 15;90(4):1656-63. Blood. 1997. PMID: 9269786 Free article. Clinical Trial.

9

Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.

Ding W, Li YP, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiernik PH, Gallagher RE. Ding W, et al. Among authors: tallman ms. Blood. 1998 Aug 15;92(4):1172-83. Blood. 1998. PMID: 9694705 Free article. Clinical Trial.

10

Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome.

Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Rowe JM, François C, Larson RS, Wiernik PH. Tallman MS, et al. Blood. 2000 Jan 1;95(1):90-5. Blood. 2000. PMID: 10607690 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

674 results

Search Page

Filters